New TNF-alpha releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen.
Herbal medicines are now attracting attention as potential sources of cancer preventive agents. Using inhibition of tumor necrosis factor-alpha (TNF-alpha) release assay, we studied Acer nikoense, Megusurino-ki in Japanese. Inhibitory potential was found in the leaf extract, and the main active principles were identified as geraniin and corilagin. The IC(50) values for TNF-alpha release inhibition were 43 microM for geraniin and 76 microM for corilagin, whereas that for (-)-epigallocatechin gallate (EGCG), the green tea polyphenol, as control was 26 microM. Furthermore, treatment with geraniin inhibited okadaic acid tumor promotion in a two-stage carcinogenesis experiment on mouse skin. Geraniin and corilagin are present in another well-known Japanese traditional herb, Geranium thunbergii, Genno-shoko in Japanese. Considering seasonal variations of the agents and sites of cultivation of herbs, this paper reviews the significance of geraniin as a new cancer preventive agent. In addition, based on accumulated results of green tea as a cancer preventive, we review two important results with EGCG: the synergistic effects of EGCG with sulindac or tamoxifen on cancer preventive activity in PC-9 cells, and cancer prevention of intestinal tumor development in multiple intestinal neoplasia (Min) mice by cotreatment using EGCG with sulindac. We report here new findings on additional gene expression resulting from cotreatment with EGCG and sulindac in PC-9 cells compared with gene expression by EGCG alone or sulindac alone. Overall, our results indicate that, with the continuing spread of cancer chemoprevention as a fundamental medical strategy, both clinicians and researchers should take a closer look at herbal medicine.
Fujiki
Hirota
H
Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-Cho, Tokushima 770-8514, Japan. hfujiki@ph.bunri-u.ac.jp
Suganuma
Masami
M
Kurusu
Miki
M
Okabe
Sachiko
S
Imayoshi
Yoko
Y
Taniguchi
Shoko
S
Yoshida
Takashi
T
D016475:3T3 Cells; D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002392:Catechin / Q000031:analogs & derivatives* / Q000494:pharmacology*; D005960:Glucosides / Q000494:pharmacology; D029001:Herbal Medicine; D047348:Hydrolyzable Tannins; D007564:Japan; D008519:Medicine, Traditional; D051379:Mice; D018514:Plant Structures / Q000737:chemistry*; D013467:Sulindac / Q000494:pharmacology*; D013629:Tamoxifen / Q000494:pharmacology*; D013634:Tannins / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000378:metabolism*
D016588:Anticarcinogenic Agents; D000970:Antineoplastic Agents; D005960:Glucosides; D047348:Hydrolyzable Tannins; D013634:Tannins; D014409:Tumor Necrosis Factor-alpha; D013629:Tamoxifen; D013467:Sulindac; C024603:Geraniin; C049096:corilagin; D002392:Catechin; C045651:epigallocatechin gallate